The researchers say botox injections could help anyone with chronic pain arising from nerve injury BawdenTom reports
The re-engineered botox would be able to treat thesuffering shooting neuropathic pain due to nerve injury from disease, trauma and infection such as stroke, multiple sclerosis, diabetes, cancer, shingles and surgery.
The new treatment was found to be highly effective in rats, cutting their pain by 80 per cent, according to a study published in the journalAnd the researchers said it might be even more effective in humans – although they note that some pain is necessary to ensure people protect their injuries, as “pain essentially aids healing”.
Non-paralysing botox wouldn’t initially be used to alleviate inflammatory pain, such as that from arthritis, although there may be some applications in areas of pain that don’t arise from nerve injury further down the line. Maria Maiaru, from the University of Reading, said: “People with chronic pain need new options for managing their symptoms. They need safer and more effective drugs.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Intermittent fasting vs. calorie restriction: which diet reduces the risk of type 2 diabetes more?Intermittent fasting vs. calorie restriction: which diet reduces the risk of type 2 diabetes more? NatureMedicine UniofAdelaide intermittentfasting caloriedefecit calorierestriction T2D type2diabetes research diet news
Read more »
Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity pain - Journal of Cannabis ResearchIntroduction Cannabidiol (CBD) is a potential therapeutic for pain management. Yet, there exists a dearth of studies of its tolerability and efficacy, especially in special populations. Former elite athletes are a special population both susceptible to chronic pain and also highly trained and attuned to assess medication tolerability concerns. The purpose of the present open-label pilot study was to assess the tolerability of CBD in this population. Materials and methods Retrospective analysis was conducted in deidentified data from 20 individuals who were all previously professional athletes in US/American football, track and field, or basketball, with careers ranging from 4 to 10 years. Participants received topical CBD (10 mg twice daily by controlled dispenser) for chronic pain resulting from acute lower extremity injuries. Assessments of tolerability and secondary analyses of pain, pain-related disability, and activities of daily living were collected by self-report over the 6-week study period. Data were analyzed by descriptive statistics, pairwise t-test, and linear regression. Results Seventy percent of participants completed the study. Of the individuals who completed the study, 50% reported minor adverse effects, none of which required medical attention, and 50% did not report any adverse effects. The mostly commonly reported effects were skin dryness (43% of study completers) and skin rash (21% of study completers), which rapidly resolved. There was a significant improvement in self-reported pain levels (intake mean 3.5 ± 0.29; exit mean 1.7 ± 0.23; P | 0.001) and pain-related disability, including family and home responsibilities, life support activities, occupational activities, recreational activities, self-care, sexual function, and social activities (all P | 0.001). Discussion To the best of our knowledge, this is the first study to assess CBD treatment in elite athletes, who are disproportionally susceptible to disabling injuries. Topical administra
Read more »
Liverpool Echo - Grand National solus formGet the latest Grand National news straight to your inbox with our newsletter:
Read more »
Grand National 2024 tickets: How to get priority accessThe official sign up form is now available
Read more »
Premier League form table updated - Now looking very interestingPremier League form table updated - Now looking very interesting nufc epl
Read more »